Skip to content

Model 483-01 Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K844267

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK844267 Date28 Mar 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 483-01 Pacing Lead is a permanent pacemaker electrode, designed to deliver electrical impulses to the heart for the treatment of bradycardia or other cardiac conduction disorders. It is classified as a Class III medical device under FDA regulations, requiring stringent pre-market approval due to its critical role in cardiac pacing therapy.

This lead is intended for implantation within the cardiovascular system, typically positioned in the right atrium or ventricle to stimulate cardiac contractions. Supplied sterile and intended for single-use, it is regulated under FDA 510(k) clearance (K844267) and adheres to the regulatory requirements outlined in 21 CFR 870.3680. Proper handling, sterile storage, and adherence to manufacturer instructions are essential for safe use.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 483-01 Pacing Lead, and where is it typically implanted in the body?

    The Model 483-01 Pacing Lead is designed to deliver electrical impulses to the heart, specifically for treating bradycardia or other cardiac conduction disorders. It is intended for implantation within the cardiovascular system, where it is typically positioned in either the right atrium or the right ventricle to stimulate cardiac contractions and maintain proper heart rhythm.

  • Is the Model 483-01 Pacing Lead intended for single-use or reusable applications, and how should it be stored?

    The Model 483-01 Pacing Lead is supplied sterile and intended for single-use only. To maintain sterility and ensure safe use, it must be stored according to the manufacturer’s instructions, which likely include keeping it in its original packaging and protecting it from contamination until implantation.

  • What regulatory pathway was followed for FDA clearance of this device, and which advisory committee was involved?

    The Model 483-01 Pacing Lead received FDA clearance through a 510(k) submission (K844267) under the Traditional Review pathway, determined to be *substantially equivalent* to a predicate device. The submission was reviewed by the Cardiovascular (CV) Advisory Committee, reflecting its classification as a Class III medical device under 21 CFR 870.3680.

  • Does this device require any special handling or preparation before use, beyond standard sterile procedures?

    Beyond standard sterile handling, the Model 483-01 Pacing Lead must be used in accordance with the manufacturer’s instructions to ensure proper implantation and functionality. Since it is intended for permanent use, adherence to sterile techniques during surgery and careful adherence to the provided guidelines are critical to avoid complications or device failure.